Literature DB >> 15624540

Dietary fructose intolerance: diet modification can impact self-rated health and symptom control.

Frederick C Johlin1, Mary Panther, Nancy Kraft.   

Abstract

Carbohydrate intolerance to lactose is widely accepted as a cause of gastrointestinal symptoms, but controversy persists on how important dietary fructose intolerance (DFI) is in causing gastrointestinal pain and suffering and if an elimination diet can control the presenting complaints. The objective of this study was to identify a group of well-defined DFI patients and explore whether dietary education followed by dietary compliance could control symptoms and improve quality of life. During a 5-year period, patients referred to a pancreato-biliary clinic were evaluated for dietary carbohydrate intolerances if they presented with gastrointestinal pain and/or gas and/or bloating and/or diarrhea. Patients were tested with a standardized mixture of glucose, fructose, and lactose diluted in sterile water. End-expiratory breath samples were collected for hydrogen and methane measurement. Symptoms were scored using a 9-point symptom questionnaire. The patients underwent in-depth education by a dietician, and were provided with access to a cookbook, a newsletter, and a support group. A dietary questionnaire was used to evaluate compliance with the fructose-restricted diet. DFI can cause significant gastrointestinal symptoms that may not respond to medications or surgical interventions. Symptoms can improve and self-rated health does improve in DFI patients willing to adhere to a low fructose diet.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15624540

Source DB:  PubMed          Journal:  Nutr Clin Care        ISSN: 1096-6781


  16 in total

1.  Fructose malabsorption is not uncommon among patients with irritable bowel syndrome in India: a case-control study.

Authors:  Atul Sharma; Deepakshi Srivastava; Abhai Verma; Asha Misra; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2014-07-29

2.  Management Strategies for Abdominal Bloating and Distension.

Authors:  Anna Foley; Rebecca Burgell; Jacqueline S Barrett; Peter R Gibson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-09

3.  Is fructose malabsorption a cause of irritable bowel syndrome?

Authors:  James J DiNicolantonio; Sean C Lucan
Journal:  Med Hypotheses       Date:  2015-06-02       Impact factor: 1.538

4.  Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria.

Authors:  Leif Kyrre Berg; Erik Fagerli; Arnt-Otto Myhre; Jon Florholmen; Rasmus Goll
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

5.  Clinical and Metabolomic Effects of Lactiplantibacillus plantarum and Pediococcus acidilactici in Fructose Intolerant Patients.

Authors:  Piero Portincasa; Giuseppe Celano; Nadia Serale; Paola Vitellio; Francesco Maria Calabrese; Alexandra Chira; Liliana David; Dan L Dumitrascu; Maria De Angelis
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

Review 6.  Fructose-sorbitol malabsorption.

Authors:  Fernando Fernández-Bañares; Maria Esteve; Josep M Viver
Journal:  Curr Gastroenterol Rep       Date:  2009-10

7.  Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy?

Authors:  Marisa Spencer; William D Chey; Shanti Eswaran
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

8.  Ability of the normal human small intestine to absorb fructose: evaluation by breath testing.

Authors:  Satish S C Rao; Ashok Attaluri; Leslie Anderson; Phyllis Stumbo
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

Review 9.  Breath tests and irritable bowel syndrome.

Authors:  Satya Vati Rana; Aastha Malik
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 10.  Fructose malabsorption and intolerance: effects of fructose with and without simultaneous glucose ingestion.

Authors:  Marie E Latulippe; Suzanne M Skoog
Journal:  Crit Rev Food Sci Nutr       Date:  2011-08       Impact factor: 11.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.